• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines Polyhalopyridines

Introduction to (4-Bromo-2-fluoropyridin-3-yl)methanol (CAS No. 1240618-32-9)

(4-Bromo-2-fluoropyridin-3-yl)methanol (CAS No. 1240618-32-9) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique bromo and fluoro substituents on a pyridine ring, exhibits a range of biological activities and has been explored for its potential applications in drug discovery and development.

The chemical structure of (4-Bromo-2-fluoropyridin-3-yl)methanol consists of a pyridine ring with a bromine atom at the 4-position, a fluorine atom at the 2-position, and a hydroxymethyl group at the 3-position. The presence of these functional groups imparts specific chemical and physical properties to the molecule, making it an attractive candidate for various synthetic transformations and biological studies.

Recent advancements in the field of medicinal chemistry have highlighted the importance of (4-Bromo-2-fluoropyridin-3-yl)methanol in the development of novel therapeutic agents. For instance, studies have shown that this compound can serve as a key intermediate in the synthesis of potent inhibitors targeting specific enzymes involved in various disease pathways. One such application is in the development of inhibitors for kinases, which are crucial enzymes implicated in cancer and inflammatory diseases.

The synthetic accessibility of (4-Bromo-2-fluoropyridin-3-yl)methanol has also been a subject of extensive research. Several efficient synthetic routes have been reported, enabling the large-scale production of this compound for further investigations. One notable method involves the bromination and fluorination of pyridine followed by a hydroxylation step to introduce the hydroxymethyl group. These synthetic strategies not only enhance the availability of the compound but also provide insights into its reactivity and potential modifications.

In addition to its role as an intermediate, (4-Bromo-2-fluoropyridin-3-yl)methanol has been evaluated for its direct biological activities. Preclinical studies have demonstrated that this compound exhibits promising antiproliferative effects against various cancer cell lines. The mechanism underlying these effects is believed to involve the modulation of key signaling pathways, such as those involving MAPK and PI3K/Akt, which are critical for cell survival and proliferation.

The pharmacokinetic properties of (4-Bromo-2-fluoropyridin-3-yl)methanol have also been investigated to assess its suitability as a therapeutic agent. Studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles, suggesting its potential for further development into drug candidates. However, ongoing research is necessary to optimize these properties and address any potential toxicity concerns.

Furthermore, the use of (4-Bromo-2-fluoropyridin-3-yl)methanol in combination with other therapeutic agents has shown synergistic effects in preclinical models. This combination therapy approach has the potential to enhance treatment efficacy while reducing side effects, making it an attractive strategy for clinical translation.

In conclusion, (4-Bromo-2-fluoropyridin-3-yl)methanol (CAS No. 1240618-32-9) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it a valuable tool for drug discovery and development. Ongoing research continues to uncover new insights into its potential therapeutic uses, positioning it as a key player in the advancement of modern medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)